NBC Securities’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
NBC Securities's NBIX Position: Q3 2026 in Review
NBC Securities held its Neurocrine Biosciences (NBIX) position steady in Q3 2026 at 20 shares worth $2.84K. The position accounts for ﹤0.01% of the portfolio, ranked #2223.
NBC Securities first reported a position in NBIX in Q3 2023 and has held it in 12 quarters since. The position peaked at $3.37K in Q2 2026. 773 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.
- NBC Securities held 20 shares of Neurocrine Biosciences worth $2.84K as of Q3 2026.
- NBC Securities left its Neurocrine Biosciences share count unchanged in Q3 2026.
- Neurocrine Biosciences made up ﹤0.01% of NBC Securities's portfolio in Q3 2026, its #2223 holding.
- NBC Securities first reported a position in Neurocrine Biosciences in Q3 2023 and has held it in 12 quarters since.
- NBC Securities's Neurocrine Biosciences position peaked at $3.37K in Q2 2026.
- 773 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.
Based on NBC Securities's 13F filing for Q3 2026, filed 26 Oct 2026.